Autonomix Medical, Inc. (AMIX)
NASDAQ: AMIX · Real-Time Price · USD
2.380
-0.370 (-13.45%)
Mar 3, 2025, 4:00 PM EST - Market closed
Autonomix Medical Employees
As of March 31, 2024, Autonomix Medical had 8 total employees, including 5 full-time and 3 part-time employees. The number of employees increased by 4 or 100.00% compared to the previous year.
Employees
8
Change (1Y)
4
Growth (1Y)
100.00%
Revenue / Employee
n/a
Profits / Employee
-$1,703,375
Market Cap
5.86M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 8 | 4 | 100.00% |
Mar 31, 2023 | 4 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
AMIX News
- 11 days ago - Autonomix Medical, Inc. Selected for Podium Presentation at the 2025 CRT Annual Meeting - GlobeNewsWire
- 19 days ago - Autonomix Medical, Inc. Reports Third Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 5 weeks ago - Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment - GlobeNewsWire
- 6 weeks ago - Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025 - GlobeNewsWire
- 6 weeks ago - Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series - GlobeNewsWire
- 7 weeks ago - Autonomix Medical, Inc. Announces Abstract Highlighting Preliminary Positive Clinical Results Accepted at The Society of Interventional Oncology (SIO) 2025 Annual Scientific Meeting - GlobeNewsWire
- 2 months ago - Autonomix Medical, Inc. Announces U.S. Patent Granted Covering the Treatment of Cancerous Tumors and Cancer Related Pain with Company's Proprietary Catheter-Based Technology - GlobeNewsWire
- 3 months ago - Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025 - GlobeNewsWire